Catalyst-backed Therapure Biopharma files to go public
Therapure Biopharma Inc, a portfolio company of Canadian private equity firm Catalyst Capital Group, has filed a preliminary prospectus with Canadian securities regulatory authorities for an initial public offering. The offering has not yet been priced, however, Bloomberg reported the company is seeking to raise at least $100 million. GMP Securities, CIBC World Markets and National Bank Financial are underwriting the sale. Based in Mississauga, Ontario, Therapure is a biopharmaceutical company focused on the development, manufacture, purification, and packaging of rare and complex biotherapeutics.
27 November 2015•2 mins read
